Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia

C. Rodrigo, T. Bewick, C. Sheppard, S. Greenwood, M. Slack, C. Trotter, R. George, W. S. Lim (Nottingham, Colindale, London, Bristol, United Kingdom)

Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Session: Antibiotics, resistance and vaccines
Session type: Thematic Poster Session
Number: 2739
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Rodrigo, T. Bewick, C. Sheppard, S. Greenwood, M. Slack, C. Trotter, R. George, W. S. Lim (Nottingham, Colindale, London, Bristol, United Kingdom). Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2739

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010



Characteristics of patients with serotype 5 pneumococcal pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

Evolutionary trend of invasive pneumococcal disease according to serotypes
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016

Community adquired legionella pneumophila pneumonia in elderly patients
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Clinical peculiarities of mycoplasma infection in children with community pneumonia
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Clinical aspects of chlamydia pneumoniae pneumonia in adults
Source: Eur Respir J 2004; 24: Suppl. 48, 642s
Year: 2004

Pneumococcal carriage and serotypes distribution in patients with acute otitis media in Switzerland, 2004-2014
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013


Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Pneumococcal pneumonia frequency in adult patients at three Russian Regions
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014